medigraphic.com
ISSN 2448-5640 (Impreso)
Diario Oficial de la Sociedad Mexicana de Cirugía Cardiaca, A.C., y del Colegio Mexicano de Cirugía Cardiovascular y Torácica, A.C.

2020, Número 4

<< Anterior Siguiente >>

Cir Card Mex 2020; 5 (4)


Extracorporeal Membrane Oxygenation as a bridge: No middle ground. Folium olivae o spinam coronam. Case Series

Orozco-Hernández EJ, Gongora E, Bellot C, Wille K, Rusanov V, Mcelwee SK, Hoopes CW

Idioma: Ingles.
Referencias bibliográficas: 31
Paginas: 134-140
Archivo PDF: 340.73 Kb.


RESUMEN

Soporte de vida extracorpórea (ECSL) es un amplio término que incluye la oxigenación de membrana extracorpórea (ECMO), bypass cardiopulmonar y resucitación cardiopulmonar extracorpórea. ECMO es un dispositivo extracorpóreo de soporte vital, que efectua intercambio gaseoso y otorga flujo circulatorio continuo , para pacientes con falla severa cardiaca y/o respiratoria La evolucion tecnológica ha desencadenado un rápido incremento en la utilización de ECMO como puente a recuperación, a soportes circulatorios mecánicos de largo plazo, corazón artificial total y/o trasplante. A pesar de que hay limitada evidencia para el uso de ECMO como puente a terapias avanzadas, recientes avances en tecnología, personal especializado y protocolos de ambulación, han determinado mejores resultados en el proceso a estas estrategias especializadas. Presentamos una serie de casos de ECMO como puente a diferentes estrategias, incluyendo puente a un soporte mecánico de larga duración, trasplante cardiaco, trasplante de pulmón y trasplante de corazón-pulmon.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Kwak J, Majewski MB, Jellish WS. Extracorporeal Membrane Oxygenation: TheNew Jack-of-all-trades? J Cardiothorac Vasc Anesth 2020;34:192-207.

  2. Tay CK, Sung K, Cho YH. Clinical Pearls in Venovenous Extracorporeal LifeSupport for Adult Respiratory Failure. ASAIO J 2018;64:1-9.

  3. Thiagarajan RR, Barbaro RP, Rycus PT, et al. Extracorporeal Life Support Organizationregistry international report 2016. ASAIO J 2017; 63:60–7.

  4. den Uil CA, Akin S, Jewbali LS, et al. Short-term mechanical circulatory supportas a bridge to durable left ventricular assist device implantation in refractory cardiogenicshock: a systematic review and meta-analysis. Eur J Cardiothorac Surg2017;52:14-25.

  5. Rihal CS, Naidu SS, Givertz MM, Szeto WY, Burke JA, Kapur NK et al. 2015SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of PercutaneousMechanical Circulatory Support Devices in Cardiovascular Care: endorsedby the American Heart Assocation, the Cardiological Society of India, andSociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value bythe Canadian Association of Interventional Cardiology-Association Canadiennede Cardiologie d’intervention. J Am Coll Cardiol 2015;65: e7–26.

  6. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ et al. 2016ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure:The Task Force for the diagnosis and treatment of acute and chronic heart failureof the European Society of Cardiology (ESC) Developed with the special contributionof the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016;37:2129–200.

  7. Pagani FD, Lynch W, Swaniker F, Dyke DB, Bartlett R, Koelling T et al. Extracorporeallife support to left ventricular assist device bridge to heart transplant:A strategy to optimize survival and resource utilization. Circulation 1999;100:II206–1

  8. Hernandez-Montfort JA, Xie R, Ton VK, Meyns B, Nakatani T et al. Longitudinalimpact of temporary mechanical circulatory support on durable ventricular assistdevice outcomes: An IMACS registry propensity matched análisys. The Journal ofHeart and Lung Transplantation,2020; 39: No 2: 145-156.

  9. Batra J, Toyoda N, Goldstone AB, et al. Extracorporeal membrane oxygenationin New York State: Trends, outcomes, and implications for patient selection. CircHeart Fail 2016;9: e003179.

  10. Mori M, McCloskey G, Geirsson A, et al. Improving outcomes in INTERMACS 1category patients with pre-LVAD, awake venousarterial extracorporeal membraneoxygenation support. ASAIO J 2019; 65:819-26.

  11. DeVore AD, Hammill BG, Patel CB, et al. Intra-aortic balloon pump use beforeleft ventricular assist device implantation: insights from the INTERMACS Registry.ASAIO J 2018; 64:218-24.

  12. Fukuhara S, Takeda K, Kurlansky PA, Naka Y, Takayama H. Extracorporeal membraneoxygenation as a direct bridge to heart transplantation in adults. J ThoracCardiovasc Surg. 2018;155:1607-18.e6. doi:10.1016/j.jtcvs.2017.10.152.

  13. Sharma NS, Hartwig MG , Hayes Jr D. Extracorporeal membrane oxygenation inthe pre and post lung transplant period. Annals of Translational Medicine 2017; 5,4:1-10.

  14. Moreno Garijo J, Cypel M, McRae K, et al. The evolving role of extracorporealmembrane oxygenation in lung transplantation: Implications for anesthetic management.J Cardiothorac Vasc Anesth 2019;33: 1995–2006.

  15. Egan TM, Edwards LB. Effect of the lung allocation score on lung transplantationin the United States. J Heart Lung Transplant 2016; 35:433–9.

  16. Hakim AH, Ahmad U, McCurry KR, et al. Contemporary outcomes of extracorporealmembrane oxygenation used as bridge to lung transplantation. Ann ThoracSurg 2018; 106:192–8.

  17. Chambers DC, Yusen RD, Cherikh WS, et al. The Registry of the InternationalSociety for Heart and Lung Transplantation: Thirty-fourth Adult Lung and Heart-Lung Transplantation Report—2017; focus theme: Allograft ischemic time. JHeart Lung Transplant 2017; 36:1047–59.

  18. Extracorporeal Life Support Organization. ECLS Registry report 2016. Availableonline: http://www.elso.org/

  19. Hayanga JW, Lira A, Aboagye JK, et al. Extracorporeal membrane oxygenationas a bridge to lung transplantation: what lessons might we learn from volume andexpertise? Interact Cardiovasc Thorac Surg 2016; 22:406-10.

  20. Singer JP, Diamond JM, Gries CJ, et al. Frailty Phenotypes, Disability, and Outcomesin Adult Candidates for Lung Transplantation. Am J Respir Crit Care Med2015; 192:1325-34.

  21. Ali NA, O'Brien JM Jr, Hoffmann SP, et al. Acquired weakness, handgrip strength,and mortality in critically ill patients. Am J Respir Crit Care Med 2008; 178:261-8.

  22. Hoopes CW, Kukreja J, Golden J, Davenport DL, Diaz-Guzman E, ZwischenbergerJB. Extracorporeal membrane oxygenation as a bridge to pulmonary transplantation.J Thorac Cardiovasc Surg 2013;145

  23. Rehder KJ, Turner DA, Hartwig MG, et al. Active rehabilitation during extracorporealmembrane oxygenation as a bridge to lung transplantation. Respir Care2013; 58:1291-8.

  24. Bain JC, Turner DA, Rehder KJ, et al. Economic Outcomes of ExtracorporealMembrane Oxygenation ith and Without Ambulation as a Bridge to Lung Transplantation.Respir Care 2016; 61:1-7.

  25. Hayanga JW, Aboagye JK, Hayanga HK, et al. Extracorporeal membrane oxygenationas a bridge to lung re-transplantation: Is there a role? J Heart Lung Transplant2016; 35:901-5.

  26. Biscotti M, Bacchetta M. The "sport model": extracorporeal membrane oxygenationusing the subclavian artery. Ann Thorac Surg 2014; 98:1487-9.

  27. Hoopes CW. Ambulatory Extracorporeal Membrane Oxygenation. http://dx.doi.org/10.1053/j.optechstcvs.2014.09.002.

  28. Rajagopal K, Hoeper MM. State of the Art: Bridging to lung transplantation usingartificial organ support technologies. J Heart Lung Transplant 2016; 35:1385-98.

  29. Chambers DC, Cherikh WS, Cherikh WS, et al. The Registry of the InternationalSociety for Heart and Lung Transplantation: thirty-sixth adult lung and heart-lungtransplantation report 2019; focus theme: Donor and Recipient size match. J HeartLung Transplant 2019;38: 1042-55.

  30. Chambers DC, Cherikh WS, Goldfarb S, et al. The Registry of the InternationalSociety for Heart and Lung Transplantation: thirty-fifth adult heart transplantationreport 2018; focus theme: multiorgan transplantation. J Heart Lung Transplant2018; 37:1169-83.

  31. Sertic F, Crespo MM, Habertheuer A, et al. Early Outcomes with the Use of ExtraCorporeal Membrane Oxygenation as a Bridge to Combined Heart and LungTransplant. Heart Lung Transplant 2019; 38 (4) (Suppl): page s55. https://doi.org/10.1016/j.healun.2019.01.120.




2020     |     www.medigraphic.com